The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis

We conducted a prospective genomic screening trial with high throughput sequencing and copy number variation (CNV) assay, and immunohistochemistry array in metastatic solid cancer patients. We used Ion AmpliSeq Cancer Hotspot Panel v2 and nCounter Copy Number Variation Assay (21 genes) to identify m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seung Tae, Lee, Jeeyun, Hong, Mineui, Park, Kyunghee, Park, Joon Oh, Ahn, Tae Jin, Park, Se Hoon, Park, Young Suk, Lim, Ho Yeong, Sun, Jong-Mu, Ahn, Jin Seok, Ahn, Myung-Ju, Kim, Hee Cheol, Sohn, Tae Sung, Choi, Dong Il, Cho, Jong Ho, Heo, Jin Seok, Kwon, Wooil, Uhm, Sang Won, Lee, Hyuk, Min, Byung-Hoon, Hong, Sung No, Kim, Duk Hwan, Jung, Sin Ho, Park, Woongyang, Kim, Kyoung-Mee, Kang, Won Ki, Park, Keunchil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741771/
https://www.ncbi.nlm.nih.gov/pubmed/26396172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741771/
https://www.ncbi.nlm.nih.gov/pubmed/26396172

Ejemplares similares